Company news

Solana Company news in 2021

Solana Company's news releases, calls and decks from 2021, newest first.

View company

Helius Medical Technologies, Inc. Partners with the Medical University of South Carolina in Pilot Trial on Stroke

December 16, 2021

Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®

December 13, 2021

Helius Medical Technologies, Inc.’s Dr. Antonella Favit-Van Pelt to Present at 4th International Brain Stimulation Conference on December 9

December 5, 2021

Helius Medical Technologies, Inc. to Participate in 1x1 Meetings at 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021

November 14, 2021

Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option

November 11, 2021

Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results

November 9, 2021

Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock

November 9, 2021

Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common Stock

November 8, 2021

Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site

November 7, 2021

Helius Medical Technologies, Inc. Receives PoNS® Market Authorization in Australia

November 3, 2021

Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021

October 31, 2021

Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference

October 11, 2021

Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference

September 21, 2021

Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors

September 13, 2021

Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 6, 2021

Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange

August 24, 2021

Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke

August 16, 2021

Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results

August 11, 2021

Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

August 10, 2021

Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July

July 11, 2021

Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer

July 7, 2021

Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics

July 6, 2021

Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

June 29, 2021

Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer

June 14, 2021

Helius Medical Technologies, Inc. to Participate in Noble Capital Markets’ Virtual Road Show Series

June 7, 2021

Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America

June 1, 2021

Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results

May 16, 2021

Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st

April 14, 2021

Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

April 6, 2021

Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device

March 28, 2021

Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd

March 16, 2021

Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors

March 16, 2021

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

March 9, 2021

Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021

February 1, 2021

Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

January 31, 2021

Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market

January 27, 2021

Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices

January 19, 2021

Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards

January 18, 2021

Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference

January 14, 2021

Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis

January 10, 2021

Helius Medical Technologies, Inc. Comments on Unusual Market Activity

January 4, 2021

Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January

January 3, 2021

Calls in 2021

Decks in 2021